New conversation tool aims to improve End-of-Life care for kidney patients

NCT ID NCT04466865

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a communication tool called 'Best Case/Worst Case' for older adults with advanced kidney disease. Doctors were trained to discuss best, worst, and most likely outcomes for treatment options. The goal was to see if this approach helps patients receive more palliative care and make decisions that match their preferences. Over 400 patients from ten clinics took part, with follow-up for up to two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Best Case/Worst Case communication tool training
What this could lead to
If this works, it could help doctors and patients have better conversations about treatment choices and end-of-life care, leading to more personalized care plans.
What could go wrong
This is a completed study testing a communication method, not a drug or cure. The tool may not change actual care or outcomes, and results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMUNICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University

    New York, New York, 10027, United States

  • Department of Medicine, University of Vermont

    Burlington, Vermont, 05405, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21287, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Mount Sinai School of Medicine

    New York, New York, 10029, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • University of Colorado, Denver

    Denver, Colorado, 173364, United States

  • University of Michigan

    Ann Arbor, Michigan, 48105, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

  • University of Washington

    Seattle, Washington, 98195, United States

  • West Virginia University

    Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.